AI Portfolio Summary
In 2026 Q1, Squadron Capital Management LLC maintained a portfolio of 53 distinct positions. The most significant new addition to the portfolio was NEKTAR THERAPEUTICS, which now represents 3.30% of the total fund value. They heavily accumulated shares in RELMADA THERAPEUTICS, increasing their position by 26.5%. Conversely, Squadron Capital Management LLC completely exited their position in CLIMB BIO INC.
Total Positions
53
Quarter
2026 Q1
Top Holding
RLMD (21.6%)
Top 10 Concentration
67.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 53
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RLMD
RELMADA THERAPE...
|
Healthcare | 21.61% | 13.71% |
#1
Prev: #1
|
8.5 | 1,774,571 | 26.5% |
P
S
|
8,474,571 | $58,983,014 |
$5.28
+32.5%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 11.11% | 11.74% |
#2
Prev: #2
|
6.0 | 7,492 | 1.0% |
P
S
|
787,492 | $30,310,567 |
$35.55
-1.0%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 7.27% | 4.79% |
#3
2
Prev: #5
|
6.4 | 285,100 | 40.7% |
P
S
|
985,100 | $19,830,063 |
$18.10
+10.0%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 5.31% | 3.46% |
#4
5
Prev: #9
|
5.1 | 88,290 | 30.3% |
P
S
|
380,000 | $14,485,600 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 5.30% | 8.29% |
#5
1
Prev: #4
|
3.1 | -15,000 | -10.3% |
P
S
|
130,000 | $14,475,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 4.04% | 3.68% |
#6
1
Prev: #7
|
2.6 | no change | no change |
P
S
|
350,000 | $11,025,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 3.30% | — |
#7
Prev: #—
|
4.8 | 125,000 | no change |
NEW
|
125,000 | $8,993,750 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANL
ADLAI NORTYE LT...
|
Healthcare | 3.21% | — |
#8
Prev: #—
|
4.8 | 1,265,231 | no change |
NEW
|
1,265,231 | $8,755,398 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 3.11% | — |
#9
Prev: #—
|
4.7 | 3,631,000 | no change |
NEW
|
3,631,000 | $8,496,540 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.82% | 8.60% |
#10
7
Prev: #3
|
1.1 | -232,500 | -47.4% |
P
S
|
257,500 | $7,686,375 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SCYX
SCYNEXIS INC
|
Healthcare | 2.56% | — |
#11
Prev: #—
|
4.5 | 7,608,695 | no change |
NEW
|
7,608,695 | $6,976,412 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 2.45% | — |
#12
Prev: #—
|
4.5 | 672,500 | no change |
NEW
|
672,500 | $6,691,375 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
CALL
KALVISTA PHARMA...
|
Healthcare | 2.32% | — |
#13
Prev: #—
|
4.4 | 315,000 | no change |
NEW
|
315,000 | $6,340,950 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 2.17% | — |
#14
Prev: #—
|
4.4 | 2,250,000 | no change |
NEW
|
2,250,000 | $5,917,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 2.15% | 3.67% |
#15
7
Prev: #8
|
1.4 | -725,000 | -17.2% |
P
S
|
3,500,000 | $5,880,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 1.92% | 4.48% |
#16
10
Prev: #6
|
0.8 | -1,500,000 | -33.3% |
P
S
|
3,000,000 | $5,250,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 1.80% | 1.60% |
#17
4
Prev: #21
|
3.2 | 180,000 | 36.0% |
P
S
|
680,000 | $4,923,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 1.67% | 1.70% |
#18
2
Prev: #20
|
1.2 | 10,000 | 3.2% |
P
S
|
325,000 | $4,569,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
PUT
KARYOPHARM THER...
|
Healthcare | 1.53% | — |
#19
Prev: #—
|
4.1 | 750,000 | no change |
NEW
|
750,000 | $4,177,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PMN
PROMIS NEUROSCI...
|
Healthcare | 1.51% | — |
#20
Prev: #—
|
4.1 | 324,977 | no change |
NEW
|
324,977 | $4,127,208 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IDYA
PUT
IDEAYA BIOSCIEN...
|
Healthcare | 1.47% | — |
#21
Prev: #—
|
4.1 | 120,000 | no change |
NEW
|
120,000 | $3,998,400 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LPCN
LIPOCINE INC NE...
|
Healthcare | 1.32% | 1.80% |
#22
4
Prev: #18
|
1.0 | -80,000 | -15.1% |
P
S
|
450,000 | $3,595,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IDYA
CALL
IDEAYA BIOSCIEN...
|
Healthcare | 1.27% | — |
#23
Prev: #—
|
4.0 | 104,300 | no change |
NEW
|
104,300 | $3,475,276 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 1.09% | 0.59% |
#24
5
Prev: #29
|
3.4 | 235,000 | 78.3% |
P
S
|
535,000 | $2,969,250 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 1.07% | — |
#25
Prev: #—
|
3.9 | 1,460,000 | no change |
NEW
|
1,460,000 | $2,927,300 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 1.06% | — |
#26
Prev: #—
|
3.9 | 1,100,000 | no change |
NEW
|
1,100,000 | $2,882,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 1.04% | 1.42% |
#27
4
Prev: #23
|
2.4 | 28,034 | 11.8% |
P
S
|
265,000 | $2,830,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVBP
CALL
ARRIVENT BIOPHA...
|
Healthcare | 0.93% | — |
#28
Prev: #—
|
3.9 | 110,000 | no change |
NEW
|
110,000 | $2,537,700 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLGL
SOL-GEL TECHNOL...
|
Healthcare | 0.90% | — |
#29
Prev: #—
|
3.9 | 31,000 | no change |
NEW
|
31,000 | $2,455,820 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KTTA
PASITHEA THERAP...
|
Healthcare | 0.57% | 1.15% |
#30
4
Prev: #26
|
1.2 | no change | no change |
P
S
|
2,100,000 | $1,557,780 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
CALL
RELAY THERAPEUT...
|
Healthcare | 0.55% | — |
#31
Prev: #—
|
3.7 | 150,000 | no change |
NEW
|
150,000 | $1,492,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TRAW
TRAWS PHARMA IN...
|
Healthcare | 0.34% | 0.34% |
#32
1
Prev: #31
|
0.1 | -201,826 | -28.3% |
P
S
|
511,714 | $936,437 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZNTL
CALL
ZENTALIS PHARMA...
|
Healthcare | 0.34% | — |
#33
Prev: #—
|
3.6 | 400,000 | no change |
NEW
|
400,000 | $936,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TXMD
THERAPEUTICSMD ...
|
Healthcare | 0.31% | — |
#34
Prev: #—
|
3.6 | 420,421 | no change |
NEW
|
420,421 | $849,250 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.29% | 2.58% |
#35
21
Prev: #14
|
0.1 | -57,800 | -82.6% |
P
S
|
12,200 | $797,270 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HOWL
WEREWOLF THERAP...
|
Healthcare | 0.17% | — |
#36
Prev: #—
|
3.6 | 563,535 | no change |
NEW
|
563,535 | $469,199 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NEUP
NEUPHORIA THERA...
|
Healthcare | 0.11% | — |
#37
Prev: #—
|
3.5 | 76,728 | no change |
NEW
|
76,728 | $312,283 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #33) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTLA
CALL
INTELLIA THERAP...
|
CALL Option | 0.00% | 0.31% |
Sold All 😨
(Was: #32) |
0.0 | -81,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZBIO
CALL
ZENAS BIOPHARMA...
|
CALL Option | 0.00% | 0.55% |
Sold All 😨
(Was: #30) |
0.0 | -36,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 1.00% |
Sold All 😨
(Was: #28) |
0.0 | -130,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.00% | 1.14% |
Sold All 😨
(Was: #27) |
0.0 | -388,287 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.00% | 1.26% |
Sold All 😨
(Was: #25) |
0.0 | -175,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
CALL
VERA THERAPEUTI...
|
CALL Option | 0.00% | 1.29% |
Sold All 😨
(Was: #24) |
0.0 | -60,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 1.57% |
Sold All 😨
(Was: #22) |
0.0 | -410,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 0.00% | 1.76% |
Sold All 😨
(Was: #19) |
0.0 | -26,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.00% | 1.82% |
Sold All 😨
(Was: #17) |
0.0 | -525,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.00% | 1.95% |
Sold All 😨
(Was: #16) |
0.0 | -240,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.00% | 2.00% |
Sold All 😨
(Was: #15) |
0.0 | -105,551 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.00% | 2.65% |
Sold All 😨
(Was: #13) |
0.0 | -230,650 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 53 holdings